블로그
- FDA] FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S. For Immediate Release July 29, 2026 The U.S. Food and Drug Administration today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plas
- FDA] FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multipl For Immediate Release August 07, 2026 The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for CLiK Extra (dicyclanil topical
- FDA] FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and For Immediate Release August 13, 2026 The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, mox
- FDA] FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food Food and Drug Administration today announced two actions targeting petroleum-based color additives in The FDA is issuing a final order revoking the authorized use of Orange B as a color additive in food
- FDA] FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Chol For Immediate Release July 17, 2026 The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase sub
- FDA] FDA Expands Sunscreen Options for the First Time in 20 Years For Immediate Release June 09, 2026 Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marki
- FDA 승인, 알츠하이머병 위기 해결을 위한 C2N의 혁신적 솔루션 제공 성과를 이어가다 #알츠하이머 #C2N #인포마켓 #강용운 FDA 승인, 알츠하이머병 위기 해결을 위한 C2N의 혁신적 솔루션 제공 성과를 이어가다 PrecivityAD2®, 진단을 돕기 위해 고해상도 제공하여, 의료 전문가가 초기 단계에서 임상적 알츠하이머병을 판정(Rule-in) 및 배제(Rule-out)할 수 있도록 지원 2026년 8월 20일, 세인트루이스 (ST.
- [Philippines FDA] FDA Advisory No.2026-0862 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0862 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “ROBB Methyl Salicylate Ointment 25 g” Updated: 2026-08-03 The Food and Drug Administration (FDA
- [Philippines FDA] FDA Advisory No.2026-0816 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0816 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Alcohol Pad 75% Alcohol” Updated: 2026-07-30 The Food and Drug Administration (FDA) advises
- [Philippines FDA] FDA Advisory No.2026-0814 || Public Health Warning Against the Purchase and Use of FDA Advisory No.2026-0814 || Public Health Warning Against the Purchase and Use of the Unregistered Drug “Tirz Laine Tirzepatide 30mg/3 mL 99% Purity” Updated: 2026-07-30 The Food and Drug Administration (FDA
1 페이지
다음 →